Thalassemia and Sickle Cell Centre Rughwani Child Care Center and Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rughwani, Vinky
BREEZE-AD-PEDS, NCT03952559 / 2018-000349-38: A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

Active, not recruiting
3
516
Europe, Japan, RoW
Baricitinib, LY3009104, Placebo, Topical corticosteroid
Eli Lilly and Company, Incyte Corporation
Atopic Dermatitis
04/22
05/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rughwani, Vinky
BREEZE-AD-PEDS, NCT03952559 / 2018-000349-38: A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

Active, not recruiting
3
516
Europe, Japan, RoW
Baricitinib, LY3009104, Placebo, Topical corticosteroid
Eli Lilly and Company, Incyte Corporation
Atopic Dermatitis
04/22
05/26

Download Options